CardioNerds Dr. Rick Ferraro, Dr. Gurleen Kaur, and Dr. Maryam Barkhordarian discuss the evidence and data supporting SGLT inhibition for cardiovascular and kidney health outcomes with expert faculty Dr. Muthu Vaduganathan. They discuss the role of SGLT inhibitors in different populations, including those with diabetes mellitus, heart failure, CKD, and myoca ... Show More
Nov 7
434. Heart Failure: Advanced Therapies Evaluation with Dr. Michelle Kittleson
CardioNerds kicks off its advanced therapies series with Chair of the CardioNerds Heart Failure Council, Dr. Jenna Skowronski, co-chair of the series, Dr. Shazli Khan, and Episode FIT lead, Dr. Jason Feinman. In this first episode, they discuss the process of advanced therapies e ... Show More
14m 1s
Nov 5
433. The Evolution and Future of Cardio-Obstetrics with Dr. Afshan Hameed, Dr. Doreen DeFaria Yeh, Dr. Garima Sharma, and Dr. Rina Mauricio
In this second episode of a collaborative series with the AHA Women in Cardiology (WIC) Committee, CardioNerds (Dr. Gurleen Kaur and Dr. Anna Radhakrishnan) are joined by four leading experts in Cardio-Obstetrics to explore this rapidly evolving field. Dr. Rina Mauricio (Director ... Show More
31m 35s
Sep 12
Sep 12 2025 This Week in Cardiology
More from ESC including: Valvular HD guidelines, a new drug class for HTN, myosin inhibition in HCM, vericiguat, and digoxin are the topic discussed by John Mandrola, MD. This podcast is intended for healthcare professionals only. To read a partial transcript or to comment, visit ... Show More
31m 5s
Feb 2025
#337 - Insulin resistance masterclass: The full body impact of metabolic dysfunction and prevention, diagnosis, and treatment | Ralph DeFronzo, M.D.
<p><a href= "https://peterattiamd.com/ralphdefronzo/?utm_source=podcast-feed&utm_medium=referral&utm_campaign=250224-pod-ralphdefronzo&utm_content=250224-pod-ralphdefronzo-podfeed"> View the Show Notes Page for This Episode</a></p> <p><a href= "https://peterattiamd.com/subscribe/ ... Show More
2h 26m
Feb 2025
#334 - Cardiovascular disease, the number one killer: development, biomarkers, apoB, cholesterol, brain health, and more | Tom Dayspring, M.D.
<p><a href= "https://peterattiamd.com/tomdayspring7/?utm_source=podcast-feed&utm_medium=referral&utm_campaign=250203-pod-tomdayspring7&utm_content=250203-pod-tomdayspring7-podfeed"> View the Show Notes Page for This Episode</a></p> <p><a href= "https://peterattiamd.com/subscribe/ ... Show More
2h 17m
Nov 2020
Covid-19 and comorbidities
A recent meta-analysis by Espinosa and colleagues, “Prevalence of Comorbidities in Patients and Mortality Cases Affected by SARS-CoV2”, found that 42% of patients with Covid-19 had comorbidities. Furthermore, 61% of those with Covid-19 admitted to the Intensive Care Unit had como ... Show More
14m 43s
Jan 2025
Review of the Primary Angioplasty in Myocardial Infarction Study Group trial
N Engl J Med 1993;328:673-679Background: Previous trials established that thrombolysis improves mortality in patients with acute myocardial infarction, as seen in the GISSI-1 and ISIS-2 trials. However, thrombolysis has limitations, including an increased risk of bleeding and the ... Show More
12m 26s
Dec 2022
PARP Inhibitors in Advanced Prostate Cancer Care
PARP Inhibitors in Advanced Prostate Cancer Care Podcast
CME Available: https://auau.auanet.org/node/37321
Host: Jay D. Raman, MD, FACS
Guests: Maha Hussain, MD and Ganesh Raj, MD, PhD
LEARNING OBJECTIVES
At the conclusion of this activity, participants will be able to:
1. Identi ... Show More
40m 20s